Search Results

Showing results 1991 - 2000 for weill cornell connect patient portal

Icon for "Old Weill Business Gateway" will be removed from myApps on 2/29 | Information Technologies & Services

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://its.weill.cornell.edu/news/icon-for-old-weill-business-gateway-will-be-removed-from-myapps-on-229

Webinars | New York Comprehensive Thalassemia Center

...Cornell Connect Newsletter Sign-Up COVID-19 UPDATE Weill Cornell Medicine Care Discover Teach...

https://thalassemia.weill.cornell.edu/care-resources/webinars

2013-2014-annual-report-final.pdf

...on-line bill payment via Weill Cornell Connect  Implemented patient questionnaires via Weill Cornell...

https://its.weill.cornell.edu/sites/default/files/2013-2014-annual-report-final.pdf

Anti-ART1 Monoclonal Antibody for Improved Anticancer Immunotherapy | Enterprise Innovation

...Weill Cornell Medicine © Weill Cornell Medicine....

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/anti-art1-monoclonal-antibody-improved-anticancer

The Charlson Comorbidity Index: A System for Identifying Patients with High Future Healthcare Costs | Enterprise Innovation

...Weill Cornell Medicine © Weill Cornell Medicine....

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/charlson-comorbidity-index-system-identifying

Methods and Reagents for Determination and Treatment of Organotropic Metastasis | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/methods-and-reagents-determination-and-treatment

DARC Diagnostic Test for Tumor Immunotherapy | Enterprise Innovation

...Weill Cornell Medicine © Weill Cornell Medicine....

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/darc-diagnostic-test-tumor-immunotherapy

Groundbreaking 20-Year Study on Gene Therapy for CLN2 Disease Shows

...Connect Departments Alumni News Events Weill Cornell Medicine....

https://geneticmedicine.weill.cornell.edu/news/groundbreaking-20-year-study-gene-therapy-cln2-disease-shows-promising-results-regarding-increased

IDA Workshop Facilitators | Division of Geriatrics and Palliative

...Connect Alumni Giving Careers Community WCM Central Newsroom Events Weill Cornell Medicine....

https://geriatrics-palliative.weill.cornell.edu/person-group/ida-workshop-facilitators

Repurposing of Reverse Transcriptase Inhibitors to Alleviate TLR5-mediated Inflammation in Cystic Fibrosis | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/repurposing-reverse-transcriptase-inhibitors

Showing results 1991 - 2000 for weill cornell connect patient portal